CheckMate 078: Patient‐Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non‐Small Cell Lung Cancer (NSCLC): OA10
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Thoracic Oncology"
DOI: 10.1016/j.jtho.2018.10.020
Abstract: Conclusion: We interrogated the characteristics of ERBB2 exon 20 insertions in a large cohort from single ethnicity. It demonstrated the response heterogeneity to afatinib among different ERBB2 exon 20 insertion subtypes. It highlighted the importance… read more here.
Keywords: reported outcomes; checkmate 078; outcomes pros; 078 patient ... See more keywords